A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a (PRTOECT)

This study has been withdrawn prior to enrollment.
(Sponsor decision to withdraw study at this time.)
Sponsor:
Information provided by:
Biogen Idec
ClinicalTrials.gov Identifier:
NCT00771043
First received: October 7, 2008
Last updated: July 29, 2009
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: June 2010
  Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)